An international research team at Mahidol University in Bangkok, Thailand, has demonstrated the potential for a new blood test to detect clinically significant prostate cancer in high-risk patients, as reported in the medical journal Cancers on July 27, 2019.
Experts explain that the technology provides far more accurate readings than other models because it works at the level of ‘nanoparticles’. It also uses artificial intelligence to identify specific chemicals, or ‘biomarkers’, produced by a range of diseases. Previous devices have only been able to detect biomarkers when present in large quantities.
Lung cancer symptoms include having a cough that won’t go away, unexplained weight loss and severe chest pain. But you could also be at risk of the disease if you have this distinctive cough. How long should you wait before seeing a doctor?